Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection
Journal of Pineal Research · 2024
DOI: 10.1111/jpi.12951 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pineal Research, 2024. Verfasst von Marie Paule Felder-Schmittbuhl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives (UPR 3212), Université de Strasbourg, Strasbourg…. Hauptthemen laut MEDLINE: Melatonin. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Melatonin is an important player in the regulation of many physiological functions within the body and in the retina. Melatonin synthesis in the retina primarily occurs during the night and its levels are low during the day. Retinal melatonin is primarily synthesized by the photoreceptors, but whether the synthesis occurs in the rods and/or cones is still unclear. Melatonin exerts its influence by binding to G protein‐coupled receptors named melatonin receptor type 1 (MT 1 ) and type 2 (MT 2 ). MT 1 and MT 2 receptors activate a wide variety of signaling pathways and both receptors are present in the vertebrate photoreceptors where they may form MT 1 /MT 2 heteromers (MT 1/2h ). Studies in rodents have shown that melatonin signaling plays an important role in the regulation of retinal dopamine levels, rod/cone coupling as well as the photopic and scotopic electroretinogram. In addition, melatonin may play an important role in protecting photoreceptors from oxidative stress and can protect photoreceptors from apoptosis. Critically, melatonin signaling is involved in the modulation of photoreceptor viability during aging and other studies have implicated melatonin in the pathogenesis of age‐related macular degeneration. Hence melatonin may represent a useful tool in the fight to protect photoreceptors—and other retinal cells—against degeneration due to aging or diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives (UPR 3212), Université de Strasbourg, Strasbourg, France.
- Department of Vision Sciences, College of Optometry, University of Houston, Houston, Texas, USA.
- Department of Pharmacology & Toxicology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Gianluca Tosini
Förderung
- NEI NIH HHS
- National Eye Institute
Zitieren
APA
Felder-Schmittbuhl, M. P., Hicks, D., Ribelayga, C. P., & Tosini, G. (2024). Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection. Journal of Pineal Research. https://doi.org/10.1111/jpi.12951
Vancouver
Felder-Schmittbuhl MP, Hicks D, Ribelayga CP, Tosini G. Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection. Journal of Pineal Research. 2024. doi:10.1111/jpi.12951
BibTeX
@article{FelderSchmittbuhl2024,
author = {Felder-Schmittbuhl, Marie Paule and Hicks, David and Ribelayga, Christophe P and Tosini, Gianluca},
title = {Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection},
journal = {Journal of Pineal Research},
year = {2024},
doi = {10.1111/jpi.12951}
}
EUVIMED